Accumulated evidence from experimental animal models suggests that neuronal loss within the dorsal horn is involved in the development and/or maintenance of peripheral neuropathic pain. However, to date, no study has specifically investigated whether such neuroanatomical changes also occur at this level in humans. Using brain imaging techniques, we sought to determine whether anatomical changes were present in the spinal trigeminal nucleus in subjects with chronic orofacial neuropathic pain. In 22 subjects with painful trigeminal neuropathy and 44 pain-free controls, voxel-based morphometry of T1-weighted anatomical images and diffusion tensor images were used to assess regional gray matter volume and microstructural changes within the brainstem. In addition, deterministic tractography was used to assess the integrity of ascending pain pathways. Orofacial neuropathic pain was associated with significant regional gray matter volume decreases, fractional anisotropy increases, and mean diffusivity decreases within the spinal trigeminal nucleus, specifically the subnucleus oralis. In addition, tractography revealed no significant differences in diffusivity properties in the root entry zone of the trigeminal nerve, the spinal trigeminal tract, or the ventral trigeminothalamic tracts in painful trigeminal neuropathy subjects compared with controls. These data reveal that chronic neuropathic pain in humans is associated with discrete alterations in the anatomy of the primary synapse. These neuroanatomical changes may be critical for the generation and/or maintenance of pathological pain.
Introduction
Half a century ago, Melzack and Loeser (1978) suggested that the maintenance of some chronic neuropathic conditions may result from neural processes well above the level of the initiating injury. More recently, structural imaging has shown that chronic neuropathic pain is associated with anatomical changes of higher brain structures, including those in the classical sensory-discriminative pain pathway such as the thalamus and somatosensory cortices (May, 2008; Tracey and Bushnell, 2009; Gustin et al., 2011) . However, Melzack and Loeser (1978) and others also acknowledged the undoubted role of peripheral/primary factors in the initiation of these higher changes (Katz and Seltzer, 2009 ). Indeed, animal models of neuropathic pain show neuroplastic changes at the primary synapse; the spinal dorsal horn, or spinal trigeminal nucleus (SpV) (Woolf, 1993; Costigan et al., 2009 ). Similar to the volumetric changes in higher brain regions of humans with pain, these animal models demonstrate neuronal degeneration/apoptosis in the superficial spinal dorsal horn or SpV (Sugimoto et al., 1990; Whiteside and Munglani, 2001; . These animal models raise the possibility that human neuropathic pain is also characterized by anatomical changes at the level of the primary synapse that may contribute to the maintenance and/or modulation of ongoing neuropathic pain.
To date, no study has focused on the anatomy at the level of the primary synapse in humans with chronic pain. This lack of focus is likely related to technical difficulties in exploring the anatomy in this extremely small region, particularly in the case of the spinal dorsal horn, in humans with magnetic resonance imaging (MRI) (Valsasina et al., 2012) . However, in the orofacial system, the SpV, including the medullary dorsal horn (SpV caudalis), lies within the caudal brainstem. Given the available spatial resolution of anatomical MRI, it is now possible to explore the anatomy of this brainstem region in humans (Lambert et al., 2013) , including those with chronic orofacial pain conditions.
The aim of this investigation was to use anatomical MRI techniques to explore brainstem anatomy, particularly the SpV, in individuals with painful trigeminal neuropathy (PTN), a chronic neuropathic pain condition that likely results from direct trauma to the trigeminal nerve (Iwata et al., 2011) . We have previously reported that this condition is associated with regional anatomical changes in higher brain areas of the pain pathway, including the thalamus, primary somatosensory cortex, and insula (Gustin et al., 2011) . Based on this evidence of central anatomical changes at higher subcortical and cortical levels (i.e., thalamus and cortex), we hypothesize that anatomical changes are also present in the preceding level of the ascending pathway, particularly at the level of the primary synapse (SpV). Voxel-based morphometry (VBM) of T1-weighted anatomical and diffusion weighted images was used to determine changes in regional brainstem anatomy and deterministic tractography to assess the integrity of ascending pathways. We hypothesized that PTN will be associated with decreased volume and diffusion changes in the SpV caudalis and altered integrity of the ascending pain pathway as a result of neuroplastic changes at the level of the primary synapse.
Materials and Methods

Subjects
Twenty-one subjects with PTN [4 males, mean age (ϮSEM): 48.7 Ϯ 1.7] and 42 age-and sex-matched pain-free controls (8 males, age: 48.6 Ϯ 2.0) were recruited. There was no significant difference in age (t test; p Ͼ 0.05) or sex composition ( 2 test, p Ͼ 0.05) between the two groups. All subjects were recruited from the Faculty of Dentistry, Westmead Hospital, University of Sydney, during a period from August 2006 to November 2012. Individual PTN subject demographics are given in Table 1 . PTN subjects were diagnosed according to the Liverpool criteria (Nurmikko and Eldridge, 2001 ) by a clinician (C.C.P.) in the research group. Controls were screened by self-report for chronic pain ( pain lasting for Ͼ3 months), current usage of analgesic medication, or any neurological disorder. Informed written consent was obtained for all procedures according to the Declaration of Helsinki and the study was approved by local institutional human research ethics committees. Some of the subjects used in this study were also used in previous investigations (Gustin et al., 2011; Gustin et al., 2012; Henderson et al., 2013; Wilcox et al., 2013) .
Pain measures
Each PTN subject's pain was assessed according to: (1) intensity as a numeric rating on a scale from 0 (no pain) to 10 (worst pain imaginable); (2) location as a distribution map of their ongoing pain onto a standard drawing of the face; and (3) quality by the McGill Pain Questionnaire (Melzack, 1975) .
MRI scans
All subjects lay supine on the bed of a 3 tesla MRI scanner (Intera; Philips) with their head immobilized in a tight-fitting head coil. In each subject, 3 high-resolution 3D T1-weighted anatomical image sets covering the entire brain were collected (turbo field echo; echo time ϭ 2.5 ms, repetition time 5600 ms, flip angle ϭ 8°, voxel size 0.8 ϫ 0.8 ϫ 0.8 mm). The three acquisitions were acquired to allow averaging for improved signal-to-noise ratios. In 16 of 21 PTN and 21 of 42 controls subjects (PTN: 3 males, mean age 48.8 Ϯ 1.6 years; controls: 2 males, mean age 50.1 Ϯ 3.3, no significant difference in age or sex), four high-resolution diffusion tensor imaging (DTI) image sets covering the entire brain were collected using a single-shot multisection spin-echo echo-planar pulse sequence (repetition time ϭ 8788 ms; flip angle ϭ 90°, matrix size ϭ 112 ϫ 112, field of view ϭ 224 ϫ 224 mm, slice thickness ϭ 2.5 mm, 55 axial slices). For each slice, diffusion gradients were applied along 32 independent orientations with b ϭ 1000 s/mm 2 after the acquisition of b ϭ 0 s/mm 2 (b 0 ) images. Four acquisitions were acquired to improve signal-to-noise ratios in measurements derived from the DTI data.
MRI analysis
Brainstem VBM. Using SPM8 (Friston et al., 1994) , the three T1-weighted images from each subject were coregistered and averaged. The mean images were segmented and spatially normalized with a dedicated symmetrical brainstem template. In brief, using the SUIT toolbox (Diedrichsen, 2006) , each image was cropped and the brainstem masked before spatial normalization. The subsequent spatial normalization and reslicing produced brainstem "maps" of gray matter probabilities modulated by the volume changes due to the normalization. Finally, the images were resliced into Montreal Neurological Institute (MNI) space and spatially smoothed using a Gaussian filter (3 mm full-width-halfmaximum). In addition, given that subjects had unilateral or asymmetrical pain, their images were reflected in the X plane ("flipped") so that changes in gray matter could be assessed ipsilateral and contralateral to the (highest) side of ongoing pain. Significant differences in gray matter between PTN and control subjects were determined using a voxel-byvoxel analysis (uncorrected, p Ͻ 0.001). Clusters of significant difference were then overlaid onto the T1-weighted template image for visualization. The location of these clusters in relation to SpV subnuclei in par- Paxinos and Huang (1995) . Individual gray matter volumes ( probability*volume) were also extracted from clusters of significant difference and correlations between these gray matter volumes and pain characteristics-that is, intensity and duration-were assessed (Pearson r, p Ͻ 0.05). In addition, to test for a possible confound of medication usage, the gray matter volumes were compared (2-sample t test) between PTN subjects using prescribed analgesic medication (n ϭ 13) and those who were not or only using NSAIDs occasionally (n ϭ 8).
Brainstem DTI. Using SPM8 and custom software, the four DTI sets were realigned based on the b0 images in each series. The diffusion tensor was calculated from the images using a linear model, and fractional anisotropy (FA) and mean diffusivity (MD) whole-brain maps were derived. These images were spatially normalized and resliced using the SUIT template as mentioned previously. This process resulted in brainstem maps of diffusion values, spatially normalized in MNI space with raw intensities preserved (nonmodulated). The images were then smoothed (3 mm full-width-half-maximum) and reflected across the midline as described above. Significant differences in diffusion values between PTN subjects and controls were determined using a voxel-byvoxel analysis (false discovery rate corrected for multiple comparisons, p Ͻ 0.005). Significant DTI differences were then overlaid onto the template T1-weighted image for visualization. Subsequently, individual diffusion values were extracted from clusters of significant difference, and correlations between MD and FA and pain characteristics-that is, pain intensity and duration-were assessed (Pearson r, p Ͻ 0.05). In addition, to test for a possible confound of medication usage, the MD values were compared (2-sample t test) between PTN subjects using analgesic medication (n ϭ 12) and those who were not (n ϭ 4).
Deterministic tractography. Tractography was performed using MrDiffusion software (Dougherty et al., 2005) based on the diffusion tensor calculated as described above. Four fiber pathways were targeted: the root entry zone (REZ) of the trigeminal nerve, the spinal trigeminal tract, and the ipsilateral and contralateral ventral trigeminothalamic tracts. Four volumes of interest were specified anatomically in each individual subject in native space: the REZ of the trigeminal nerve, the caudal SpV nucleus, the medial lemiscus in the midbrain, and the thalamus (Fig. 1 ). Fibers were tracked using a Runge-Kutta fourth-order algorithm with a minimum FA value of 0.15 and a maximum turning angle of 60°. The REZ of the trigeminal nerve was defined as encompassing the trigeminal nerve within the pontine cistern; that is, from the point at which the nerve emerges from the pons to the point at which it exits the pontine cistern anteriorly. Fibers of the trigeminal nerve that descended to SpV caudalis were classified as the spinal trigeminal tract. The ipsilateral ventral trigeminothalamic tract was defined as fibers that originated in the SpV caudalis and passed through the ipsilateral medial lemiscus to the thalamus. The contralateral trigeminothalamic tract was defined as fibers that originated in the SpV caudalis and passed through the contralateral medial lemiscus to the thalamus. The mean FA and MD diffusivity values for each of the tracts were calculated in each individual. For controls, left and right tract FA and MD values were compared using paired t tests. These were not significantly different (all p Ͼ 0.05) and were subsequently combined for comparison with PTN subjects. Finally, significant differ- 
Results
Pain characteristics
Individual PTN subject characteristics are shown in Table 1 . All of the 21 PTN subjects were classified as having posttraumatic neuropathy. In 10 of the PTN subjects, ongoing pain was unilateral (60% right, 40% left side) and the remaining subjects had bilateral pain. A cumulative distribution map of their pain distribution is shown in Figure 2 . In most PTN subjects, pain was located in the maxillary and/or mandibular nerve distributions, with most subjects reporting pain in the oral/perioral region. Their average pain intensity (numeric rating scale) was 4.7 Ϯ 0.4 and their average duration of pain was 5.5 Ϯ 0.8 years. PTN subjects most commonly described their pain as radiating (42%), shooting (29%), and sharp (29%).
Gray matter volume changes (VBM)
In PTN subjects, brainstem VBM analysis revealed significant regional gray matter volume changes in several regions (Fig. 3 , Table 2 ). Compared with control subjects, PTN subjects displayed significant reductions in gray matter volume in the ipsilateral (to higher pain) SpV. This SpV volume decrease was in the region of the subnucleus oralis (mean Ϯ SEM gray matter probability*volume: controls 0.17 Ϯ 0.006, PTN 0.14 Ϯ 0.006). Significant reductions in gray matter volume in PTN subjects also occurred in the region of the ipsilateral principal trigeminal sensory nucleus (Vp) (controls 0.21 Ϯ 0.008, PTN 0.16 Ϯ 0.010), in the contralateral middle cerebellar peduncle (MCP) (controls 0.15 Ϯ 0.007, PTN 0.10 Ϯ 0.006), and in the ipsilateral trigeminal lemniscus (TL) in the midbrain (controls 0.17 Ϯ 0.006, PTN 0.12 Ϯ 0.008). No brainstem region showed increased gray matter volume in PTN subjects compared with controls.
In PTN subjects, no significant correlations were observed between gray matter volume in any cluster of significant difference and pain intensity (SpV: r ϭ 0.02; Vp: r ϭ 0.30; MCP: r ϭ 0.36; TL: r ϭ Ϫ0.03; all p Ͼ 0.05) or pain duration (SpV: r ϭ 0.30; Vp: r ϭ Ϫ0.06; MCP: r ϭ 0.29; TL: r ϭ 0.02; all p Ͼ 0.05).
Furthermore, comparison of these clusters found no significant difference in MD values between those PTN subjects who used analgesic medication and those who did not.
DTI changes
In addition to changes in gray matter volume, DTI analysis revealed significant MD differences in a number of brainstem sites (Fig. 3, Table 2 ). Compared with controls, PTN subjects had significantly decreased MD in the region of the ipsilateral SpV; specifically, in separate clusters in the region of the subnucleus interpolaris (mean Ϯ In these significant clusters, in PTN subjects, significant correlations occurred between MD and pain intensity in the ipsilateral Vp (r ϭ 0.626, p ϭ 0.01) and between MD and pain duration in the ipsilateral nerve entry region (r ϭ 0.521, p ϭ 0.038) and the ipsilateral TL ( p ϭ 0.513, p ϭ 0.042). No other significant correlations were observed. Comparison of these clusters found no significant difference in MD values between those PTN subjects who used analgesic medication and those who did not. Furthermore, comparison of those subjects whose images were collected in the evening with those collected in the morning also resulted in significant difference in any cluster.
In addition to changes in MD, DTI analysis also revealed significant FA differences in a number of brainstem sites (Fig. 3 , Table 2 ). Compared with controls, PTN subjects displayed significantly increased FA in the region of the ipsilateral SpV; in the region of the subnucleus interpolaris and oralis (mean Ϯ SEM FA: controls 0.18 Ϯ 0.008, PTN 0.25 Ϯ 0.017), bilaterally in the region of the trigeminal nerve tract within the pons (ipsilateral: controls 0.32 Ϯ 0.009, PTN 0.41 Ϯ 0.007; contralateral: controls 0.45 Ϯ 0.012, PTN 0.51 Ϯ 0.014), and in the ipsilateral TL in the midbrain (controls 0.31 Ϯ 0.007, PTN 0.40 Ϯ 0.015). No decreases in FA were observed. In these significant clusters, in PTN subjects, significant correlations occurred between FA in the ipsilateral nerve entry region and pain intensity (r ϭ Ϫ0.579, p ϭ 0.019) and duration (r ϭ Ϫ0.513, p ϭ 0.042). No other significant correlations were observed. Furthermore, comparison of these clusters found no significant difference in MD values between those PTN subjects who used analgesic medication and those who did not and in those subjects whose images were collected in the morning compared with those collected in the evening.
DTI and VBM overlap
Brainstem regions that displayed both gray matter volume and diffusion changes were also determined. In a discrete region of the ipsilateral SpV oralis (MNI coordinates: x ϭ Ϫ8, y ϭ Ϫ40, y ϭ Ϫ47, cluster size ϭ 13 mm 3 ), gray matter volume decreased, MD decreased, and FA increased (Fig. 4) . Although no difference in gray matter volume was observed in the SpV interpolaris, discrete clusters of MD decrease and FA increase were observed, although not overlapping. Furthermore, within the SpV caudalis (MNI coordinates: x ϭ Ϫ4, y ϭ Ϫ46, y ϭ Ϫ64), no significant differences between controls and PTN subjects were 
Tractography
Tractography identified the REZ of the trigeminal nerve in all PTN and control subjects, the spinal trigeminal tract in 33% of PTN and 63% of control subjects, the ascending trigeminothalamic tract in all PTN and control subjects, and the crossing trigeminothalamic tract in all PTN and 94% of control subjects. Group analysis of the average FA and MD values in each ipsilateral and contralateral (to highest pain) tract revealed no difference in PTN subjects compared with controls in the REZ of the trigeminal nerve, the spinal trigeminal tract, the ipsilateral ventral trigeminothalmic tract, or the contralateral ventral trigeminothalamic tract. FA and MD group means for each tract are given in Table 3 .
Discussion
The results of this study reveal that chronic neuropathic pain is associated with anatomical changes in the region of the primary synapse. More specifically, PTN subjects displayed decreased gray matter volume, decreased MD, and increased FA in the region of the SpV. Strikingly, PTN subjects did not display any significant differences in the anatomy of the trigeminal nerve, the spinal trigeminal tract, nor the ventral trigeminothalamic tracts. These data suggest that chronic neuropathic pain is associated with anatomical changes at the level of the primary synapse-the SpV-whereas the anatomy of SpV afferents and efferents remains unaffected.
Because it is the generally held view that nociceptive input from the orofacial region is initially processed in SpV caudalis, Figure 3 . Regions of structural difference in subjects with PTN compared with pain-free control subjects overlaid onto template axial and coronal T1-weighted images. Slice locations in MNI space are indicated at the lower left of each image. Left, Regional gray matter volume decreases (cool color scale) in subjects with PTN compared with pain-free controls. Subjects with PTN have lower gray matter volumes in the ipsilateral (to highest ongoing pain) SpV oralis, ipsilateral Vp, contralateral MCP, and the ipsilateral TL. Middle, Regional MD decreases (cool color scale) in subjects with PTN compared with pain-free controls. Subjects with PTN have lower MD in the ipsilateral SpV oralis and interpolaris, ipsilateral V nerve entry, bilateral Vp, and ipsilateral TL. Right, Regional FA increases (hot color scale) in subjects with PTN compared with pain-free controls. Subjects with PTN have higher FA in the ipsilateral SpV oralis and interpolaris, ipsilateral V nerve entry, and the ipsilateral TL. one might initially conclude from our data that PTN is not associated with changes in the region of the primary synapse. However, behavioral, anatomical, and electrophysiological evidence from experimental animal investigations suggest that more rostral nuclei, including SpV oralis, SpV interpolaris, and Vp, have a primary role in processing noxious input from oral and perioral regions (Sessle and Greenwood, 1976; Marfurt and Turner, 1984; Sessle, 2000) . In the majority of PTN subjects in this investigation, the presumptive initiating event was a dental procedure and the distribution of their ongoing pain was centered in oral and perioral regions. This characteristic likely accounts for our findings of a volumetric loss specifically within the SpV oralis and Vp without anatomical changes in SpV caudalis. The nature of the cellular changes underlying the detected MRI changes is unclear. Although a decrease in gray matter volume may result from neuronal loss, it may also result from shrinkage or atrophy of neurons or glia or synaptic loss (May and Gaser, 2006) . In addition, MD and FA are markers of more subtle changes in tissue microstructure that may result from tissue shrinkage and dense packing of myelinated fibers as a result of neurodegeneration and gliosis (Sierra et al., 2011) . Consistent with our findings, animal models of neuropathic pain show nerve injury evokes neuronal degeneration in the region of recipient primary synapse (Sugimoto et al., 1990; Azkue et al., 1998; Whiteside and Munglani, 2001; de Novellis et al., 2004; Scholz et al., 2005) . This neuronal degeneration is thought to result from excessive, ongoing afferent excitation (Sloviter and Damiano, 1981; Coggeshall et al., 1993) , a theory supported by reports that myelinated primary afferents in nerve-injured animals discharge ectopically at high frequencies, thus providing aberrant excitatory input (Khan et al., 2002; Chaplan et al., 2003; Amir et al., 2005) that in turn is responsible for the protracted induction of neuronal loss (Coggeshall et al., 1993; Scholz et al., 2005) . Furthermore, the number of neurons in superficial laminae is reduced by ϳ22% at 4 weeks after injury, including a ϳ25% loss of GABAergic inhibitory interneurons . This inhibitory neuron loss is likely responsible for the observed decrease in dorsal horn postsynaptic inhibition (Moore et al., 2002) . Dorsal horn neuronal degeneration appears to play an important role in the establishment of chronic pain because a reduction of this neuronal loss by administration of caspase apoptosis inhibitors reduces the occurrence of neuropathic pain-like behaviors in experimental animals (Whiteside and Munglani, 2001; Scholz et al., 2005) .
In direct contrast to the anatomical changes at the primary synapse, the afferent and efferent projections appear unaffected. At first glance, this lack of change is surprising given that the etiology of PTN is often attributed to direct trauma of the trigeminal nerve or any of its tributaries (Benoliel et al., 2012) . Although we did not find significant diffusion differences along the spinal trigeminal tract, we did find localized diffusion changes in the pons in the region where the trigeminal nerve enters. Furthermore, the degree of change was significantly correlated to ongoing pain intensity and duration. Given that, at this entry point, large diameter fibers are tracking toward Vp and small diameter fibers to the spinal trigeminal tract, it is possible that the diffusion change results from this fiber separation. Indeed, we also found significant diffusion changes in Vp, which may suggest that these changes are related to altered large diameter fibers synapsing in Vp. It is possible that these changes are associated with the altered central processing of innocuous somatosensory stimuli that occurs in PTN subjects (Gustin et al., 2012) .
With regard to the peripheral nerve, in animal models of neuropathic pain, neuromas form at the site of nerve injury and both myelinated and unmyelinated axons show a marked decrease distal to the site of injury, but the nerve proximal to the injury is spared this neuronal loss (Carlton et al., 1991; Stanisz et al., 2001) . Furthermore, after an extended period, the distal degeneration of the nerve undergoes significant regeneration such that it appears essentially normal (Gautron et al., 1990; Coggeshall et al., 1993; Stanisz et al., 2001; Taylor and Ribeiro-da-Silva, 2011) . These findings are consistent with our data in that we found no diffusion differences in the REZ of the trigeminal nerve or in the spinal trigeminal tract in PTN subjects, suggesting that, in the long term, the proximal microstructure of the trigeminal nerve is not altered (Stanisz et al., 2001 ). This is supported by our previous investigation in which we found volumetric and crosssectional area increases in the REZ of the trigeminal nerve in PTN subjects (Wilcox et al., 2013) , perhaps as a result of this regeneration (Watson et al., 2007) .
We also found no difference in the diffusion properties of the ipsilateral or contralateral ventral trigeminothalamic tract in PTN subjects, suggesting that the integrity of this tract is not substantially altered. We did, however, find discrete diffusion and volume changes in the midbrain region encompassing the trigeminal lemniscus, the degree of which was significantly correlated to ongoing pain intensity. Given the lack of change in fibers ascending from SpV, this change may reflect altered large diameter afferent changes from fibers ascending from Vp, although the degree of change was correlated with ongoing pain, suggesting a small diameter effect. The trigeminothalamic tract conveys noxious orofacial information from the SpV to the cerebral cortex largely via the somatosensory thalamus (Craig, 2004) . Although, in animal models, loss of primary afferent neurons (substance P immunoreactive fibers) and GABAergic interneurons in the dorsal horn have been shown (de Novellis et al., 2004; Scholz et al., 2005) , the fate of ascending projection neurons originating in the dorsal horn has not been specifically investigated. Despite a reported loss of ϳ22% of dorsal horn neurons, our data suggest that these are not thalamic projecting neurons. One consideration may be the relative number of ventral trigeminothalamic tract fibers originating from each SpV subnucleus because the vast majority originate in SpV caudalis and the caudalis/interpolaris transition zone, whereas SpV interpolaris and oralis projections are relatively sparse (Matsushita et al., 1982; Shigenaga et al., 1986) . Therefore, any degeneration of these fibers may be too subtle to detect using DTI methods.
Our observations of discrete anatomical changes in the region of the primary synapse, in combination with an absence of diffusion changes within the trigeminothalamic tract, complement our previous findings of a specific, regional gray matter loss within the somatosensory thalamus of PTN subjects (Gustin et al., 2011) . Indeed, it appears that a volumetric loss within the somatosensory thalamus may be a unifying observation in chronic neuropathic pain (Apkarian et al., 2004; Gustin et al., 2010) . These findings, taken together, are consistent with the idea that the neuronal changes associated with neuropathic pain are tract specific and may result from excitotoxic, trans-synaptic neuronal effects along ascending pain pathways. Although evidence of specific trans-synaptic effects is not established, some experimental animal investigations report neuronal loss in pain pathway recipient regions such as the midbrain periaqueductal gray matter (Mor et al., 2011) and the rostral ventromedial medulla (Leong et al., 2011) . Interestingly, in a previous investigation, we found no evidence of altered resting blood flow in SpV or the somatosensory thalamus in PTN subjects, although blood flow was reduced in the thalamic reticular nucleus Youssef et al., 2014) . One interpretation of these results is that neuropathic pain is does not involve overt activation of pain pathways, but instead results from changes in the pattern of neural firing. Indeed, human and experimental animal studies suggest that thalamocortical dysrhythmia may give rise to the spontaneous perception of pain in neuropathic conditions (Wang and Thompson, 2008; Walton and Llinas, 2010) .
Overall, our findings suggest that chronic neuropathic pain in humans is associated with anatomical changes in the regions of the primary synapse. This observation, together with our previous results in this pain group, serves as evidence of central anatomical changes at multiple levels of the pain pathway, which may underlie the abnormal neuronal function associated with the positive sensory symptoms (allodynia, hyperalgesia, and spontaneous pain) which occur in chronic neuropathic pain conditions. Determining the relative importance of these brain changes in the expression of these positive sensory symptoms may lead to more targeted treatments for chronic neuropathic pain.
